Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial

  1. Douglas, P.S.
  2. Umbleja, T.
  3. Bloomfield, G.S.
  4. Fichtenbaum, C.J.
  5. Zanni, M.V.
  6. Overton, E.T.
  7. Fitch, K.V.
  8. Kileel, E.M.
  9. Aberg, J.A.
  10. Currier, J.
  11. Sponseller, C.A.
  12. Melbourne, K.
  13. Avihingsanon, A.
  14. Bustorff, F.
  15. Estrada, V.
  16. Ruxrungtham, K.
  17. Saumoy, M.
  18. Navar, A.M.
  19. Hoffmann, U.
  20. Ribaudo, H.J.
  21. Grinspoon, S.
Aldizkaria:
Clinical Infectious Diseases

ISSN: 1537-6591,  1058-4838

Argitalpen urtea: 2021

Alea: 73

Zenbakia: 11

Orrialdeak: 2009-2022

Mota: Artikulua

DOI: 10.1093/CID/CIAB552 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus